Market research
FORTIS.NSE Fortis Healthcare Limited
NSE INR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 670B
- P/E ratio
- 63.87
- Analyst target
- 1114.05
- Dividend yield
- 0.0%
- Beta
- 0.65
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- INE061F01013
- Market cap
- 670B
- P/E ratio
- 63.87
- Analyst target
- 1114.05
- Dividend yield
- 0.0%
- Beta
- 0.65
About
About Fortis Healthcare Limited
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology, obstetrics and gynaecology, pediatrics, pediatrics, vascular surgery, and support facilities. It also provides services in the areas of infertility medicine, dental science, endocrine surgery, geriatric medicine, liver transplant and hepatobiliary sciences, neurology, ophthalmology, pain and palliative medicine, pulmonology, thoracic surgery, gastroenterology sciences, dermatology, ENT, haematology, medical generics, neurology, organ transplant, radiology, and transfusion medicines. In addition, the company offers various spectrum integrated healthcare services ranging from clinics to quaternary care facilities and a range of ancillary services, as well as secondary, and tertiary care services. The company's healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FORTIS.NSE discussion.
5 years, 5 months ago
Fortis Healthcare Limited is currently in a long term uptrend where the price is trading 34.7% above its 200 day moving average.
From a valuation standpoint, the stock is 8.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Fortis Healthcare Limited's total revenue rose by 0.7% to $12B since the same quarter in the previous year.
Its net income has increased by 139.2% to $299M since the same quarter in the previous year.
Finally, its free cash flow grew by 4.2% to $563M since the same quarter in the previous year.
Based on the above factors, Fortis Healthcare Limited gets an overall score of 5/5.